Oxford Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,259
| Closed | -$1.38M | – | 752 |
|
|
2019
Q4 | $1.38M | Sell |
9,259
-10,236
| -53% | -$1.53M | 0.04% | 644 |
|
|
2019
Q3 | $2.5M | Buy |
+19,495
| New | +$2.5M | 0.06% | 418 |
|
|
2019
Q2 | – | Sell |
-16,972
| Closed | -$2.43M | – | 1838 |
|
|
2019
Q1 | $2.43M | Sell |
16,972
-8,734
| -34% | -$1.25M | 0.05% | 480 |
|
|
2018
Q4 | $3.19M | Buy |
+25,706
| New | +$3.19M | 0.08% | 275 |
|
|
2018
Q3 | – | Sell |
-13,129
| Closed | -$2.27M | – | 1811 |
|
|
2018
Q2 | $2.27M | Buy |
13,129
+64
| +0.5% | +$11.1K | 0.04% | 594 |
|
|
2018
Q1 | $1.97M | Buy |
13,065
+2,382
| +22% | +$360K | 0.04% | 589 |
|
|
2017
Q4 | $1.46M | Buy |
+10,683
| New | +$1.46M | 0.03% | 741 |
|
|
2017
Q2 | – | Sell |
-31,673
| Closed | -$4.6M | – | 1582 |
|
|
2017
Q1 | $4.6M | Sell |
31,673
-7,574
| -19% | -$1.1M | 0.11% | 166 |
|
|
2016
Q4 | $4.28M | Buy |
39,247
+1,889
| +5% | +$206K | 0.15% | 129 |
|
|
2016
Q3 | $4.54M | Sell |
37,358
-33,808
| -48% | -$4.11M | 0.14% | 165 |
|
|
2016
Q2 | $10.1M | Buy |
71,166
+63,512
| +830% | +$8.97M | 0.33% | 62 |
|
|
2016
Q1 | $999K | Buy |
+7,654
| New | +$999K | 0.03% | 506 |
|
|
2015
Q4 | – | Sell |
-2,387
| Closed | -$317K | – | 910 |
|
|
2015
Q3 | $317K | Sell |
2,387
-18,710
| -89% | -$2.48M | 0.01% | 543 |
|
|
2015
Q2 | $3.72M | Sell |
21,097
-30,595
| -59% | -$5.39M | 0.1% | 226 |
|
|
2015
Q1 | $8.93M | Buy |
51,692
+21,470
| +71% | +$3.71M | 0.23% | 96 |
|
|
2014
Q4 | $5.04M | Buy |
30,222
+16,648
| +123% | +$2.77M | 0.11% | 201 |
|
|
2014
Q3 | $2.18M | Sell |
13,574
-8,953
| -40% | -$1.44M | 0.05% | 354 |
|
|
2014
Q2 | $3.31M | Sell |
22,527
-42,036
| -65% | -$6.17M | 0.11% | 272 |
|
|
2014
Q1 | $8.95M | Buy |
+64,563
| New | +$8.95M | 0.26% | 117 |
|